BH
Publications
394
Views
225,150
Downloads
12,602
Supervised works
1
Items per page
1 - 394 of 394
Title Published in Access level OA Policy Year Views Downloads
REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT'BMC medical ethics
accessLevelPublic
2023 141 76
Universal test and treat and the HIV epidemic in rural South Africa : a phase 4, open-label, community cluster randomised trialThe lancet. HIV
accessLevelPublic
2018 70 67
Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa?Frontiers in Microbiology
accessLevelPublic
2017 598 220
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular EventsJournal of acquired immune deficiency syndromes
accessLevelRestricted
2016 81 0
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2016 80 26
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisalBMC public health
accessLevelPublic
2015 84 35
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective studyEuropean journal of clinical investigation
accessLevelPrivate
2015 597 0
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsBMC gastroenterology
accessLevelPublic
2015 71 19
Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidenceLancet
accessLevelRestricted
2015 658 0
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCVInternational journal of epidemiology
accessLevelPublic
2014 755 427
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneHIV clinical trials
accessLevelRestricted
2014 75 0
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence : the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa : study protocol for a cluster randomised controlled trialTrials
accessLevelPublic
2013 95 16
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patientsPLoS computational biology
accessLevelPublic
2013 689 259
Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot studyNeurology
accessLevelRestricted
2013 801 1
Capnocytophaga canimorsus prosthetic aortitis in an HIV-positive womanJournal of clinical microbiology
accessLevelPublic
2013 709 288
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluidJournal of acquired immune deficiency syndromes and human retrovirology
accessLevelRestricted
2013 586 0
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort StudyAntiviral therapy
2013 730 0
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High FieldPloS one
accessLevelPublic
2013 781 1,155
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*HIV medicine
accessLevelRestricted
2012 603 1
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumoniaAIDS
accessLevelRestricted
2012 660 0
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccinePloS one
accessLevelPublic
2012 759 323
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinationsClinical infectious diseases
accessLevelPublic
2012 1,072 262
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
accessLevelRestricted
2012 712 0
Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infectionsAIDS
accessLevelPublic
2012 731 432
Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype BClinical infectious diseases
accessLevelPublic
2011 577 384
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infectionClinical infectious diseases
accessLevelPublic
2011 896 755
Severe leptospirosis with multiple organ failure successfully treated by plasma exchange and high-volume hemofiltrationCase Reports in Nephrology and Dialysis
accessLevelPublic
2011 476 183
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 1,038 594
Ageing with HIV : medication use and risk for potential drug-drug interactionsJournal of antimicrobial chemotherapy
accessLevelRestricted
2011 54 0
Successful efavirenz dose reduction guided by therapeutic drug monitoringAntiviral therapy
accessLevelRestricted
2011 50 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 862 8
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2011 629 0
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infectionGut
accessLevelRestricted
2011 735 0
VIH/SIDA : nombreuses nouveautésRevue médicale suisse
accessLevelPublic
2011 68 106
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort StudyJournal of translational medicine
accessLevelPublic
2011 649 294
The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in SwitzerlandThe Journal of infectious diseases
accessLevelPublic
2011 659 600
Human herpes virus type 8 seroprevalence in pregnant women in Geneva, SwitzerlandJournal of maternal-fetal & neonatal medicine
accessLevelRestricted
2011 649 0
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitorsJournal of acquired immune deficiency syndromes
accessLevelPublic
2011 710 1,609
No Longitudinal Mitochondrial DNA Sequence Changes in HIV-infected Individuals With and Without LipoatrophyScandinavian journal of infectious diseases
accessLevelPublic
2011 960 171
HIV treatment for preventionJournal of the International AIDS Society
accessLevelPublic
2011 62 22
Clinical relevance of cytomegalovirus viraemiaHIV medicine
accessLevelRestricted
2011 646 0
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapyGut
accessLevelRestricted
2010 647 0
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2010 571 0
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadirAIDS
accessLevelRestricted
2010 628 0
Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infectionsThe Journal of infectious diseases
accessLevelRestricted
2010 640 0
"Swiss statement": bilan deux ans aprèsRevue médicale suisse
2010 578 0
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in SwitzerlandThe Journal of infectious diseases
accessLevelRestricted
2010 607 0
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral loadPLOS pathogens
accessLevelPublic
2010 733 495
HIV drugs for treatment, and for preventionLancet
accessLevelRestricted
2010 603 0
Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case reportJournal of medical case reports
accessLevelPublic
2010 731 311
Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitorsInternational journal of infectious diseases
accessLevelRestricted
2010 588 0
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaClinical infectious diseases
accessLevelRestricted
2010 603 0
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individualsClinical infectious diseases
accessLevelRestricted
2010 645 0
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort studyClinical infectious diseases
accessLevelRestricted
2010 607 0
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2Journal of acquired immune deficiency syndromes
accessLevelRestricted
2010 612 0
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008Archives of internal medicine
accessLevelRestricted
2010 542 0
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresJournal of acquired immune deficiency syndromes
accessLevelRestricted
2010 625 0
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialHIV medicine
accessLevelRestricted
2010 576 0
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infectionClinical infectious diseases
accessLevelRestricted
2010 517 0
Cognitive dysfunction in HIV patients despite long-standing suppression of viremiaAIDS
accessLevelRestricted
2010 908 1
Health perceptions of African HIV-infected patients and their physiciansPatient education and counseling
accessLevelRestricted
2010 631 0
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyGastroenterology
accessLevelRestricted
2010 877 0
A new era of antiretroviral drug toxicityAntiviral therapy
2009 583 0
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapyJournal of clinical epidemiology
accessLevelRestricted
2009 495 0
Cas importés d'histoptasmoseRevue médicale suisse
2009 621 0
Is it smart to continue to study treatment interruptions?AIDS
accessLevelRestricted
2009 556 0
Nouveau spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapiesRevue médicale suisse
2009 572 0
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2009 490 0
Education thérapeutique en maladie infectieuse : l'exemple de l'infection à VIHRevue médicale suisse
2009 640 0
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS
accessLevelRestricted
2009 651 0
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infectionAIDS
accessLevelRestricted
2009 566 0
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samplesSexually transmitted infections
accessLevelRestricted
2009 590 0
VIH-sidaRevue médicale suisse
2009 475 0
Safety and efficacy of once-daily nevirapine dosing: a multicohort studyAntiviral therapy
2009 648 0
How reliable is an undetectable viral load?HIV medicine
accessLevelRestricted
2009 562 0
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine : a nested case-control studyClinical infectious diseases
accessLevelRestricted
2009 66 0
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007PloS one
accessLevelPublic
2009 1,122 791
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureHepatology
accessLevelRestricted
2009 612 0
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort StudyAntiviral therapy
2009 510 0
Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case reportJournal of medical case reports
accessLevelPublic
2009 677 587
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individualsHIV clinical trials
2009 519 0
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in SwitzerlandClinical infectious diseases
accessLevelRestricted
2009 628 0
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal studyCirculation. Cardiovascular genetics
accessLevelRestricted
2009 531 0
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIVAntiviral therapy
2009 581 0
The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patientsThe Open AIDS journal
accessLevelPublic
2009 682 383
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional studyThe Journal of infectious diseases
accessLevelRestricted
2009 590 0
HIV transmission under highly active antiretroviral therapyLancet
accessLevelRestricted
2008 586 0
Antiretroviral treatment during pregnancyAIDS
accessLevelRestricted
2008 664 0
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovirClinical infectious diseases
accessLevelRestricted
2008 583 0
Dix ans de lipodystrophie (1998-2008) : un syndrome encore méconnuRevue médicale suisse
accessLevelPublic
2008 574 152
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenAIDS
accessLevelRestricted
2008 548 0
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2008 589 0
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelRestricted
2008 637 0
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavirAntiviral therapy
accessLevelRestricted
2008 541 0
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish journal of cancer
accessLevelRestricted
2008 630 0
Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment FailureThe Open virology journal
accessLevelPublic
2008 671 733
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control studyHIV medicine
accessLevelRestricted
2008 627 0
Preference for CD4-guided versus continuous HARRT in ThailandAIDS care
2008 585 0
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infectionAIDS
accessLevelRestricted
2008 619 0
The Monark trial: where now for boosted protease inhibitor monotherapy?AIDS
accessLevelRestricted
2008 550 0
PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnellesRevue médicale suisse
2008 491 0
Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited settingInternational journal of STD & AIDS
2008 615 0
Initial treatment for HIV infection--an embarrassment of richesThe New England journal of medicine
accessLevelRestricted
2008 598 0
HIV transmission hunting--the chase for low risk eventsAntiviral therapy
accessLevelRestricted
2008 491 0
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy eraAIDS
accessLevelRestricted
2008 675 0
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapyClinical infectious diseases
accessLevelRestricted
2008 539 0
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort StudyAntiviral therapy
accessLevelRestricted
2008 397 0
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudyThe journal of antimicrobial chemotherapy
accessLevelRestricted
2008 622 0
HIV rebounds from latently infected cells, rather than from continuing low-level replicationProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2008 602 0
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsAntiviral therapy
accessLevelRestricted
2008 521 0
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infectionThe New England journal of medicine
accessLevelRestricted
2008 675 0
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006HIV medicine
accessLevelRestricted
2008 603 0
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapyClinical infectious diseases
accessLevelRestricted
2008 600 0
Ferritin levels during structured treatment interruption of highly active antiretroviral therapyHIV medicine
accessLevelRestricted
2007 496 0
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapyPharmacogenetics and genomics
accessLevelRestricted
2007 617 0
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAIDS
accessLevelRestricted
2007 511 0
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progressionJournal of virology
accessLevelRestricted
2007 577 0
Clinical update: adverse effects of antiretroviral therapyLancet
accessLevelRestricted
2007 621 0
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort StudyAntiviral therapy
accessLevelRestricted
2007 610 0
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort StudyAIDS
accessLevelRestricted
2007 580 0
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJournal of internal medicine
accessLevelRestricted
2007 555 0
No patient left behind--better treatments for resistant HIV infectionLancet
accessLevelRestricted
2007 560 0
VIH – sida Traitement de l'infection à VIH en 2006 : points fortsRevue médicale suisse
2007 558 0
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort StudyHIV clinical trials
accessLevelRestricted
2007 574 0
No change in calculated creatinine clearance after tenofovir initiation among Thai patientsThe journal of antimicrobial chemotherapy
accessLevelRestricted
2007 513 0
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort StudyClinical infectious diseases
accessLevelRestricted
2007 511 0
Treatment interruption for convenience, cost cutting and toxicity sparingCurrent opinion in HIV and AIDS
accessLevelRestricted
2007 592 0
HIV viral load monitoring in resource-limited regions: optional or necessary?Clinical infectious diseases
accessLevelRestricted
2007 619 1
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmissionClinical infectious diseases
accessLevelRestricted
2007 569 0
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen typesArchives of internal medicine
accessLevelRestricted
2007 595 0
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort StudyAntiviral therapy
accessLevelRestricted
2007 511 0
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapyAntiviral therapy
accessLevelRestricted
2007 506 0
Review on structured treatment interruptions (STIs)Topics in HIV medicine
accessLevelRestricted
2007 408 0
Intermittent therapy for the treatment of chronic HIV infectionAIDS
accessLevelRestricted
2007 561 0
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapyAntiviral therapy
accessLevelRestricted
2007 552 0
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) TrialAIDS
accessLevelRestricted
2007 631 0
Late presentation of HIV-infected individualsAntiviral therapy
accessLevelRestricted
2007 521 0
The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral loadArchives of internal medicine
accessLevelRestricted
2007 484 0
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modificationAntiviral therapy
accessLevelRestricted
2007 571 1
Increased incidence of sexually transmitted infections in Geneva, SwitzerlandDermatology
accessLevelRestricted
2006 722 0
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2006 582 0
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort studyAntiviral therapy
accessLevelRestricted
2006 479 0
HIV and solid organ transplantation: the Swiss experienceSchweizerische medizinische Wochenschrift
accessLevelPublic
2006 474 147
Molecular biology of squamous cell carcinoma of the anusBritish journal of surgery
accessLevelRestricted
2006 766 0
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2006 466 0
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialLancet
accessLevelRestricted
2006 656 0
Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavirAntiviral therapy
accessLevelRestricted
2006 517 0
Immunological recovery and antiretroviral therapy in HIV-1 infectionLancet. Infectious diseases
accessLevelRestricted
2006 539 1
Sida Molécules récentes, stratégies thérapeutiques d'avenir et nouvelles cibles du traitementRevue médicale suisse
2005 1,361 0
Interrupting highly active antiretroviral therapy in patients with HIVExpert review of anti-infective therapy
2005 625 0
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort StudyClinical infectious diseases
accessLevelRestricted
2005 660 0
Biphasic decline of CD4 cell count during scheduled treatment interruptionsAIDS
accessLevelRestricted
2005 614 0
Effect of rimonabant on weight reduction and cardiovascular riskLancet
accessLevelRestricted
2005 528 0
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patientsAntiviral therapy
accessLevelRestricted
2005 533 0
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 studyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2005 494 0
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersThe Journal of infectious diseases
accessLevelRestricted
2005 498 0
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infectionClinical infectious diseases
accessLevelRestricted
2005 609 0
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell lossJournal of acquired immune deficiency syndromes
accessLevelRestricted
2005 587 0
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort studyAntiviral therapy
accessLevelRestricted
2005 509 0
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptionsJournal of virology
accessLevelRestricted
2005 441 0
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovirAIDS
accessLevelRestricted
2005 557 0
Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infectionArchives of dermatology
accessLevelRestricted
2005 693 0
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyAntiviral therapy
accessLevelRestricted
2005 569 0
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapyClinical infectious diseases
accessLevelRestricted
2005 575 0
Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear stainingEuropean journal of clinical microbiology & infectious diseases
accessLevelPublic
2005 570 229
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control studyAIDS
accessLevelRestricted
2004 610 0
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control studyAIDS research and human retroviruses
accessLevelRestricted
2004 638 0
The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysisJournal of acquired immune deficiency syndromes
accessLevelRestricted
2004 600 0
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infectionAntiviral therapy
accessLevelRestricted
2004 472 0
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3Journal of acquired immune deficiency syndromes
accessLevelRestricted
2004 589 0
Antibiotics for acute rhinosinusitisArchives of internal medicine
accessLevelRestricted
2004 549 0
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort studyBMJ. British medical journal
accessLevelRestricted
2004 549 0
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mgAntiviral therapy
accessLevelRestricted
2004 506 0
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set pointBlood
accessLevelRestricted
2004 617 0
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptionsAIDS
accessLevelRestricted
2004 620 0
Infrequent transmission of HIV-1 drug-resistant variantsAntiviral therapy
accessLevelRestricted
2004 575 0
Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nefThe Journal of infectious diseases
accessLevelRestricted
2004 591 0
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDSProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2004 595 0
Traitement par cidofovir topique d'infections cutanées à papillomavirus humain, poxvirus et Herpes simplex virus chez des malades séropositifs pour le VIHAnnales de dermatologie et de vénéréologie
accessLevelRestricted
2004 823 0
HIV-PrimoinfektionTherapeutische Umschau
2004 569 0
Is unsafe sexual behaviour increasing among HIV-infected individuals?AIDS
accessLevelRestricted
2004 575 0
L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functionsNutrition
accessLevelRestricted
2004 658 0
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapyThe Journal of infectious diseases
accessLevelRestricted
2004 613 0
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-dailyThe journal of antimicrobial chemotherapy
accessLevelRestricted
2004 609 0
HIV--vereinfachte bis gar keine BehandlungTherapeutische Umschau
2004 590 0
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAARTAIDS
accessLevelRestricted
2003 532 0
Prophylaxie post-exposition au VIHRevue médicale de la Suisse romande
2003 600 0
Beware of drug holidays before HIV salvage therapyThe New England journal of medicine
accessLevelRestricted
2003 535 0
Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptionsThe Journal of infectious diseases
accessLevelRestricted
2003 584 0
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alAIDS
accessLevelRestricted
2003 463 0
Structured treatment interruptions in HIV infection: benefit or disappointment?Expert review of anti-infective therapy
2003 517 0
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infectionJournal of virology
accessLevelRestricted
2003 549 0
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general populationLancet
accessLevelRestricted
2003 569 0
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2003 556 0
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alAIDS
accessLevelRestricted
2003 426 0
Caspofungin in the treatment of oropharyngeal candidiasisInternational journal of clinical practice
2003 577 0
Antiretroviral treatment and research in resource-poor countriesLancet
accessLevelRestricted
2003 485 0
Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivoAntiviral therapy
accessLevelRestricted
2003 527 0
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionArchives of internal medicine
accessLevelRestricted
2003 607 0
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialAIDS
accessLevelRestricted
2003 602 0
Questions about the antimalarial amodiaquineLancet
accessLevelRestricted
2003 462 0
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort StudyArchives of internal medicine
accessLevelRestricted
2003 557 0
Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDSJournal of acquired immune deficiency syndromes
accessLevelRestricted
2003 648 0
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et alAIDS
accessLevelRestricted
2003 483 0
Is autovaccination dead?Research initiative, treatment action
2003 474 0
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapyAIDS
accessLevelRestricted
2003 535 0
Drug resistance mutations during structured treatment interruptionsAntiviral therapy
accessLevelRestricted
2003 545 0
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survivalAIDS
accessLevelRestricted
2003 526 0
HIV RNA in plasma rebounds within days during structured treatment interruptionsAIDS
accessLevelRestricted
2003 510 0
Substitution for protease inhibitors in HIV therapyThe New England journal of medicine
accessLevelRestricted
2003 564 0
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infectionClinical infectious diseases
accessLevelRestricted
2003 559 0
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus loadAIDS
accessLevelRestricted
2002 510 0
Supervised interruptions of antiretroviral therapyAIDS
accessLevelRestricted
2002 406 0
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2002 570 0
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national studyNutrition
accessLevelRestricted
2002 593 0
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6)AIDS
accessLevelRestricted
2002 437 0
New drugs, old drugs - dear drugs, cheap drugsSchweizerische medizinische Wochenschrift
accessLevelRestricted
2002 495 0
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individualAIDS
accessLevelRestricted
2002 557 0
Clinical features of acute retroviral syndrome differ by route of infection but not by gender and ageJournal of acquired immune deficiency syndromes
accessLevelRestricted
2002 603 0
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV CohortAIDS
accessLevelRestricted
2002 577 0
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyAntiviral therapy
accessLevelRestricted
2002 457 0
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyAIDS
accessLevelRestricted
2002 558 0
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapyJournal of virology
accessLevelRestricted
2002 524 0
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionThe Journal of infectious diseases
accessLevelRestricted
2002 633 0
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2002 522 0
A patient with HIV-1 superinfectionThe New England journal of medicine
accessLevelRestricted
2002 549 0
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2002 472 0
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort studyAIDS
accessLevelRestricted
2002 589 0
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus loadJournal of clinical immunology
accessLevelRestricted
2002 563 0
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcriptsAntiviral therapy
accessLevelRestricted
2002 539 0
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus loadEuropean Journal of Immunology
accessLevelRestricted
2001 513 0
HIV transmission after suspension of highly active antiretroviral therapyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2001 540 0
Planned interruptions of anti-HIV treatmentLancet. Infectious diseases
accessLevelRestricted
2001 545 0
Investigations of axillary and inguinal adenopathies during primary human immunodeficiency virus infection: other lymphadenopathies could bring additional informationThe Journal of infectious diseases
accessLevelRestricted
2001 552 0
Modern anti-HIV therapySchweizerische medizinische Wochenschrift
accessLevelRestricted
2001 533 0
Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospitalAIDS patient care and STDs
accessLevelRestricted
2001 652 0
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000Schweizerische medizinische Wochenschrift
accessLevelRestricted
2001 502 0
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceAIDS
accessLevelRestricted
2001 510 0
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyLancet
accessLevelRestricted
2001 850 0
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyAIDS
accessLevelRestricted
2001 602 0
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsHIV medicine
accessLevelRestricted
2001 601 0
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyClinical infectious diseases
accessLevelRestricted
2001 536 0
Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitisEuropean journal of clinical microbiology & infectious diseases
accessLevelRestricted
2001 590 0
Symptomes, signes cliniques et radiologiques prédictifs de l'origine bactérienne des rhino-sinusites aiguësSchweizerische medizinische Wochenschrift
2000 599 0
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyAIDS
accessLevelRestricted
2000 523 0
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolatesAIDS
accessLevelRestricted
2000 439 0
Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort StudyThe Journal of infection
accessLevelRestricted
2000 522 0
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDSThe Journal of infectious diseases
accessLevelRestricted
2000 667 0
Regional differences in presentation of AIDS in EuropeEpidemiology and infection
accessLevelRestricted
2000 566 0
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
2000 482 0
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and SydneyAIDS
accessLevelRestricted
2000 578 0
Zweitinfektion mit HIV: Mythos oder Realitat?Schweizerische medizinische Wochenschrift
2000 546 0
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infectionAIDS
accessLevelRestricted
2000 557 0
VIH: épidemiologie et traitement--2000Revue médicale de la Suisse romande
2000 505 0
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
2000 548 0
An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDSJournal of the American Academy of Dermatology
accessLevelRestricted
2000 607 0
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study GroupAntimicrobial agents and chemotherapy
accessLevelRestricted
2000 581 0
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyLancet
accessLevelRestricted
2000 502 0
Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort studyThe Journal of infectious diseases
accessLevelRestricted
1999 568 0
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyThe New England journal of medicine
accessLevelRestricted
1999 509 0
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapyThe Journal of infectious diseases
accessLevelRestricted
1999 518 0
Prophylaxie post exposition au VIH: eligibilite des patients récemment infectés par voie sexuelleSchweizerische medizinische Wochenschrift
1999 720 0
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1999 496 0
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelRestricted
1999 568 0
The year in review: antiretroviral treatmentAIDS
1999 495 0
Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort StudyDiagnostic molecular pathology
accessLevelRestricted
1999 628 0
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyJAMA
accessLevelRestricted
1999 586 0
Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infectionJournal of acquired immune deficiency syndromes
accessLevelRestricted
1999 515 0
A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort StudyInternational journal of STD & AIDS
1999 476 0
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1999 560 0
Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavenseDiagnostic microbiology and infectious disease
accessLevelRestricted
1999 625 0
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyLancet
accessLevelRestricted
1999 516 0
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupJournal of acquired immune deficiency syndromes and human retrovirology
1998 501 0
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1998 495 0
A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1998 629 0
Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV StudyAIDS
accessLevelRestricted
1998 601 0
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyAntiviral therapy
1998 493 0
Colour vision in AIDS patients without HIV retinopathyVision research
accessLevelRestricted
1998 593 0
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigenThe Journal of experimental medicine
accessLevelRestricted
1998 505 0
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationshipClinical infectious diseases
accessLevelRestricted
1998 557 0
Microaerophilic conditions promote growth of Mycobacterium genavenseJournal of clinical microbiology
accessLevelRestricted
1998 628 0
16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA geneJournal of clinical microbiology
accessLevelRestricted
1998 598 0
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIVThe Journal of infectious diseases
accessLevelRestricted
1998 605 0
Radiological maxillary sinusitis in patients with common coldJournal of family practice
1998 538 0
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort StudyArchives of internal medicine
accessLevelRestricted
1998 533 0
Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapyThe Journal of infectious diseases
accessLevelRestricted
1998 540 0
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variantsJournal of virology
accessLevelRestricted
1998 558 0
Progress and problems in the fight against AIDSThe New England journal of medicine
1998 494 0
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995AIDS
accessLevelRestricted
1998 657 2
Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot studyJournal of the American Academy of Dermatology
accessLevelRestricted
1998 638 0
Antiretroviral therapy: a guide to the most important trialsSchweizerische medizinische Wochenschrift
1997 541 0
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1997 518 0
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudineClinical microbiology and infection
accessLevelRestricted
1997 661 0
Adding saquinavir to stavudine in patients with advanced HIV-1 infectionAIDS
1997 515 0
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort StudyAmerican journal of respiratory and critical care medicine
1997 577 0
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort StudyBMJ. British medical journal
accessLevelRestricted
1997 538 0
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortEuropean Journal of Immunology
accessLevelRestricted
1997 644 0
Effet du traitement antirétroviral sur les manifestations électroencéphalographiques et otoneurologiques précoces de l'infection à VIH et signification pronostique des perturbations constatéesNeurophysiologie clinique
accessLevelRestricted
1997 540 1
Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary culturesJournal of clinical microbiology
accessLevelRestricted
1997 549 0
Detection of Mycobacterium avium-intracellulare in the blood of HIV-infected patients by a commercial polymerase chain reaction kitEuropean journal of clinical microbiology & infectious diseases
accessLevelRestricted
1997 520 0
Zidovudine plus didanosine in primary HIV-1 infectionAntiviral therapy
1997 580 0
Duration of hospitalization during the first two years after AIDS diagnosis: a descriptive studySozial- und Präventivmedizin
accessLevelPublic
1997 613 291
Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?Clinical infectious diseases
accessLevelRestricted
1997 576 0
Test tuberculinique, chimioprophylaxie antituberculeuse et incidence de la tuberculose dans l'étude suisse de cohorte VIHRevue d'épidémiologie et de santé publique
1997 499 0
Chemotherapy for AIDS-related malignancies does not increase HIV viraemiaAIDS
1997 494 0
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study GroupClinical infectious diseases
accessLevelRestricted
1997 520 0
Two different 16S rRNA genes in a mycobacterial strainJournal of clinical microbiology
accessLevelRestricted
1996 589 0
Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcomeThe Journal of infectious diseases
accessLevelRestricted
1996 613 0
Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort StudyAIDS
accessLevelRestricted
1996 559 0
Disseminierte Infektion mit Mycobacterium celatumSchweizerische medizinische Wochenschrift
1996 619 0
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretionsLancet
accessLevelRestricted
1996 636 1
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy childThe Pediatric infectious disease journal
1996 641 0
Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L'étude suisse de cohorte VIHSchweizerische medizinische Wochenschrift
1996 553 0
Combined therapy with zidovudine and L-697,661 in primary HIV infectionAIDS
accessLevelRestricted
1996 573 0
Controversies: does the CD4+ cell count reflect clinical efficacy?JAMA
1996 553 0
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsAntiviral therapy
1996 442 0
Infection VIH, tuberculose et test tuberculinique en Suisse. The Swiss HIV Cohort StudySchweizerische medizinische Wochenschrift
1996 589 0
Combination therapy in primary HIV infectionAntiviral research
accessLevelRestricted
1996 570 0
Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort StudyThe European respiratory journal
accessLevelRestricted
1996 587 0
Capnocytophaga canimorsus sepsis complicated by myocardial infarction in two patients with normal coronary arteriesClinical infectious diseases
accessLevelRestricted
1996 668 0
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study GroupThe Journal of infectious diseases
accessLevelRestricted
1996 558 0
Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year surveyJournal of clinical microbiology
accessLevelRestricted
1996 576 0
Red fingers syndrome in patients with HIV and hepatitis C infectionLancet
accessLevelRestricted
1996 630 0
The risk of HIV transmission by screened bloodThe New England journal of medicine
1996 559 0
Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudineClinical infectious diseases
accessLevelRestricted
1996 622 0
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupTubercle and lung disease
accessLevelRestricted
1996 533 0
Fingertip necrosis during chemotherapy with bleomycin, vincristine and methotrexate for HIV-related Kaposi's sarcomaBritish journal of dermatology
accessLevelRestricted
1996 608 0
Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia?AIDS
accessLevelRestricted
1996 451 0
HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study GroupEuropean journal of haematology
1995 548 0
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosineJournal of acquired immune deficiency syndromes and human retrovirology
1995 614 0
Human chronic gonadotropin for AIDS-related Kaposi's sarcomaLancet
accessLevelRestricted
1995 539 0
Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?Clinical microbiology and infection
accessLevelRestricted
1995 553 0
Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study GroupBMJ. British medical journal
accessLevelRestricted
1995 568 0
Pneumonia and respiratory distress syndrome during primary infection with Toxoplasma gondiiClinical infectious diseases
accessLevelRestricted
1995 530 0
Infections à Mycobacterium genavense. Fréquence et présentation cliniqueLa Presse médicale
1995 459 0
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patientsClinical infectious diseases
accessLevelRestricted
1995 669 0
Response of HIV RNA to didanosine as a predictive marker of survivalAIDS
accessLevelRestricted
1995 640 0
Single-dose pharmacokinetics of oral fleroxacin in bacteremic patientsAntimicrobial agents and chemotherapy
accessLevelRestricted
1994 593 0
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndromeMedicine
accessLevelRestricted
1992 586 0
Hospital care for patients with AIDS compared to other patients in Geneva, 1981-1988AIDS
accessLevelRestricted
1991 526 0
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumoniaThe New England journal of medicine
1991 632 0
Anti-retrovirale Therapie in der Schweiz 1991Schweizerische medizinische Wochenschrift
1991 533 0
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort StudyAnnals of internal medicine
1991 532 0
Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective studyThe Journal of infectious diseases
accessLevelRestricted
1991 535 0
Prophylaxe der infektiosen ReisekrankheitenTherapeutische Umschau
1991 486 0
Complications neurologiques de l'infection par le virus d'immunodéficience humaineLa Presse médicale
1991 464 0
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcomaKlinische Wochenschrift
1991 517 0
Neuro-otological manifestations in different stages of HIV infectionActa oto-laryngologica. Supplementum
accessLevelRestricted
1991 618 0
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989AIDS
accessLevelRestricted
1990 535 0
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndromeThe New England journal of medicine
accessLevelPublic
1990 637 141
Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDSMedizinische Klinik
1990 466 0
Antivirale Substanzen: Gegen was? Fur wen?Therapeutische Umschau
1990 539 0
A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infectionThe New England journal of medicine
accessLevelRestricted
1990 599 0
Aids und Magendarmtrakt: eine Zusammenfassung fur Gastroenterologen und ChirurgenSchweizerische medizinische Wochenschrift
1990 535 0
Indikationen und Kontraindikationen von ZidovudinDeutsche Medizinische Wochenschrift
1989 548 0
HLA antigens are risk factors for development of AIDSJournal of acquired immune deficiency syndromes
1989 544 0
Tuberculin skin reactivity in HIV-seropositive intravenous drug addictsThe New England journal of medicine
1989 543 0
Serum levels of ciprofloxacin after single oral doses in patients with septicemiaEuropean journal of clinical microbiology & infectious diseases
1989 682 0
HIV screening in an emergency departmentBMJ. British medical journal
accessLevelRestricted
1988 484 0
Négativation d'une sérologie positive pour le virus d'immunodéficience humaine (VIH). A propos de deux observationsSchweizerische medizinische Wochenschrift
1988 961 0
HIV infection: diagnosis and epidemiologySeminars in hematology
1988 394 0
Antivirale Pharmaka--1988Schweizerische medizinische Wochenschrift
1988 579 0
Hepatische Manifestationen des erwobenen Immunmangelsyndroms (AIDS)Schweizerische medizinische Wochenschrift
1988 521 0
Serological study of meningococcal isolates in Switzerland and France 1980-1986European journal of clinical microbiology & infectious diseases
1988 643 0
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infectionsThe Journal of infectious diseases
accessLevelRestricted
1987 640 0
Activation polyclonale B associee a l'infection par le virus d'immunodeficience humaine (VIH)Schweizerische medizinische Wochenschrift
1987 746 0
Lymphadénopathies persistantes généralisées chez les homosexuels et les toxicomanes: altérations de l'immunité humorale et cellulaireSchweizerische medizinische Wochenschrift
1986 693 0
Neopterin in AIDs, other immunodeficiencies, and bacterial and viral infectionsKlinische Wochenschrift
1986 605 0
Amodiaquine and hepatitisAnnals of internal medicine
1986 570 0
Antikorper gegen das AIDS-Virus: Nachweismethoden und klinische BedeutungTherapeutische Umschau
1986 553 0
Altered functions of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathyEuropean journal of clinical investigation
1986 684 0
Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinomaBMJ. British medical journal
accessLevelRestricted
1985 567 0
Listériose intraoculaireJournal français d'ophtalmologie
1985 543 0
Typhusepidemiologie in der Schweiz 1980-1983. Geringe oder fehlende Wirksamkeit des Lebendimpfstoffes Vivotif bei TropenreisendenSchweizerische medizinische Wochenschrift
1985 505 0
Meningococcal meningitis in the first case of complement deficiencyLancet
1985 562 0
Lymphadenopathic form of Kaposi's sarcoma (KS) in an African child. No evidence for acquired immunodeficiency syndrome (AIDS)Helvetica paediatrica acta
1985 574 0
Vorbeugen ist teurer als heilenSchweizerische medizinische Wochenschrift
1985 532 0
Prévention de l'hépatite B (HB): questions et réponsesSchweizerische Rundschau für Medizin PRAXIS
1985 523 0
Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid feverEuropean journal of clinical microbiology
1985 650 0
Syndrome de déficit immunitaire acquis, coccidiose chronique, et septicémie à Salmonella typhi murium chez un couple de zairois. Fonctions immunitaires et essai d'immunostimulation par la thymopentineSchweizerische medizinische Wochenschrift
1984 713 0
Mesures à prendre avant un voyage au tiers mondeSchweizerische medizinische Wochenschrift
1984 580 0
Meningococcemia in a patient with acquired complement deficiency and myelomaThe New England journal of medicine
1984 641 0
Recurrent meningitis in an adult due to nontypable Haemophilus influenzaeThe Journal of infectious diseases
accessLevelRestricted
1984 596 0
Cloning and analysis of the K1 capsule biosynthesis genes of Escherichia coli: lack of homology with Neisseria meningitidis group B DNA sequencesInfection and immunity
accessLevelRestricted
1983 576 0
Neisseria meningitidis B et E. coli K1: des gènes différents mais régissant la production d'une capsule identique. Communication préliminaireSchweizerische medizinische Wochenschrift
1983 545 0
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oubliéSchweizerische medizinische Wochenschrift
1983 745 0
Syndrome de déficience immunitaire acquise et infections opportunistes chez une femmeSchweizerische medizinische Wochenschrift
1983 530 0
Typhus abdominalis nach Impfung mit dem Lebend-Impfstoff VivotifSchweizerische medizinische Wochenschrift
1983 577 0
Failures with oral typhoid vaccine Ty 21aLancet
1983 618 0
Cointegrate formation by Tn5, but not transposition, is dependent on recAProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
1982 683 1
Structure and stability of transposon 5-mediated cointegratesJournal of Molecular Biology
accessLevelRestricted
1982 583 0
Granulation tissue as a contractile organ. A study of structure and functionThe Journal of experimental medicine
accessLevelRestricted
1972 623 0
Fibroblasts of granulation tissue: immunofluorescent staining with antismooth muscle serumProceedings of the Society for Experimental Biology and Medicine
1971 613 0
Contraction of granulation tissue in vitro: similarity to smooth muscleScience
accessLevelRestricted
1971 675 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack